The main goal of this systematic review is to summarize evidences regarding alterations of microbial composition in ADHD cases and uncover underlying mechanisms.
Methods:
A comprehensive search was conducted on PubMed, Web of Science, and Scopus databases up to March 2021. All the observational studies including case-control, cross-sectional, and cohorts investigating the correlations between the gut microbiota and ADHD in both adults and children were included.
Results:
We found eight eligible studies. Enterococcus, Bifidobacterium, and Odoribacter were increased which may lead to impaired dopamine related functions in CNS. Moreover, decrease of Faecalibacterium frequency in ADHD could result in higher permeability and crossing of inflammatory cytokines. Regarding the short chain fatty acids-producing bacteria, Ruminococcaceae family decreased and Bacteroides uniformis and Bacteroides ovatus species increased.
Conclusion:
Gut microbiota correlation with ADHD and its underlying mechanisms could open new windows for developing novel therapies of ADHD by manipulating microbiota.
AartsE.EderveenT. H. A.NaaijenJ.ZwiersM. P.BoekhorstJ.TimmermanH. M.SmeekensS. P.NeteaM. G.BuitelaarJ. K.FrankeB.van HijumS. A. F. T.Arias VasquezA. (2017). Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One, 12(9), e0183509.
2.
AgirmanG.HsiaoE. Y. (2021). SnapShot: The microbiota-gut-brain axis. Cell, 184(9), 2524–2524.e1.
3.
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (Vol. 3). American Psychiatric Association.
4.
AngooraniP.Hasani-RanjbarS.SoroushA.-R.SiadatS. D.EjtahedH.-S.SharifiF.ArzaghiS. M.FakhrzadehH.LarijaniB. (2021). The role of intestinal Microbiota in cognitive disorders. Journal of Mazandaran University of Medical Sciences, 31(193), 113–124.
5.
BanerjeeE.NandagopalK. (2015). Does serotonin deficit mediate susceptibility to ADHD?Neurochemistry International, 82, 52–68.
6.
BergS.TrollforsB.HugossonS.FernellE.SvenssonE. (2002). Long-term follow-up of children with bacterial meningitis with emphasis on behavioural characteristics. European Journal of Pediatrics, 161(6), 330–336.
7.
BranisteV.Al-AsmakhM.KowalC.AnuarF.AbbaspourA.TóthM.KoreckaA.BakocevicN.NgL. G.KunduP.GulyásB.HalldinC.HultenbyK.NilssonH.HebertH.VolpeB. T.DiamondB.PetterssonS. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine, 6(263), 263ra158.
8.
CarabottiM.SciroccoA.MaselliM. A.SeveriC. (2015). The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209.
9.
ChangZ.LichtensteinP.HalldnerL.D’OnofrioB.SerlachiusE.FazelS.LångströmN.LarssonH. (2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885.
10.
Checa-RosA.Jeréz-CaleroA.Molina-CarballoA.CampoyC.Muñoz-HoyosA. (2021). Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications. Nutrients, 13(1), 249.
11.
ChengS.HanB.DingM.WenY.MaM.ZhangL.QiX.ChengB.LiP.KafleO. P.LiangX.LiuL.DuY.ZhaoY.ZhangF. (2020). Identifying psychiatric disorder-associated gut microbiota using microbiota-related gene set enrichment analysis. Briefings in Bioinformatics, 21(3), 1016–1022.
12.
ClaytonT. A. (2012). Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Letters, 586(7), 956–961.
13.
CostantiniL.MolinariR.FarinonB.MerendinoN. (2017). Impact of omega-3 fatty acids on the gut microbiota. International Journal of Molecular Sciences, 18(12), 2645.
14.
CostelloE. J.MustilloS.KeelerG.AngoldA. (2004). Prevalence of Psychiatric Disorders in Childhood and Adolescence. In LevinB. L.PetrilaJ.HennessyK. D. (Eds.), Mental health services: A public health perspective (pp. 111–128). Oxford University Press.
15.
DamS. A.MostertJ. C.Szopinska-TokovJ. W.BloemendaalM.AmatoM.Arias-VasquezA. (2019). The role of the gut-brain axis in attention-deficit/hyperactivity disorder. Gastroenterology Clinics of North America, 48(3), 407–431.
16.
EjtahedH.-S.AngooraniP.SoroushA. R.SiadatS. D.ShirzadN.Hasani-RanjbarS.LarijaniB. (2020). Our little friends with big roles: Alterations of the gut microbiota in thyroid disorders. Endocrine Metabolic & Immune Disorders - Drug Targets, 20(3), 344–350.
17.
EjtahedH.-S.SoroushA. R.AngooraniP.LarijaniB.Hasani-RanjbarS. (2016). Gut microbiota as a target in the pathogenesis of metabolic disorders: A new approach to novel therapeutic agents. Hormone and Metabolic Research, 48(6), 349–358.
FaraoneS. V.BiedermanJ.MorleyC. P.SpencerT. J. (2008). Effect of stimulants on height and weight: A review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47(9), 994–1009.
20.
FlintH. J.ScottK. P.DuncanS. H.LouisP.ForanoE. (2012). Microbial degradation of complex carbohydrates in the gut. Gut Microbes, 3(4), 289–306.
21.
GalloE. F.PosnerJ. (2016). Moving towards causality in attention-deficit hyperactivity disorder: Overview of neural and genetic mechanisms. The Lancet Psychiatry, 3(6), 555–567.
22.
Garcia-GutierrezE.NarbadA.RodríguezJ. M. (2020). Autism spectrum disorder associated with gut microbiota at immune, metabolomic, and neuroactive level. Frontiers in Neuroscience, 14, 578666.
23.
GilliesD.SinnJ. K. H.LadS. S.LeachM. J.RossM. J. (2012). Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews, 2012(7), CD007986. https://doi.org/10.1002/14651858.CD007986.
24.
Hasani-RanjbarS.LarijaniB. (2017). Human microbiome as an approach to personalized medicine. Alternative Therapies in Health and Medicine, 23(6), 8–9.
25.
JiangH. Y.ZhouY. Y.ZhouG. L.LiY. C.YuanJ.LiX. H.RuanB. (2018). Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorder. Behavioural Brain Research, 347, 408–413.
26.
KimK. M.LimM. H.KwonH. J.YooS. J.KimE. J.KimJ. W.HaM.PaikK. C. (2018). Associations between attention-deficit/hyperactivity disorder symptoms and dietary habits in elementary school children. Appetite, 127, 274–279.
27.
Maini RekdalV.BessE. N.BisanzJ. E.TurnbaughP. J.BalskusE. P. (2019). Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science, 364(6445), eaau6323.
28.
MaL. L.WangY. Y.YangZ. H.HuangD.WengH.ZengX. T. (2020). Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better?Military Medical Research, 7(1), 7.
29.
MingX.ChenN.RayC.BrewerG.KornitzerJ.SteerR. A. (2018). A gut feeling: A hypothesis of the role of the microbiome in attention-deficit/hyperactivity disorders. Child Neurology Open, 5, 2329048X18786799.
30.
MoherD.ShamseerL.ClarkeM.GhersiD.LiberatiA.PetticrewM.ShekelleP.StewartL. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1–9.
31.
MontioliR.BattiniR.PaiardiniA.TolveM.BertoldiM.CarducciC.LeuzziV.Borri VoltattorniC. (2019). A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies. Molecular Genetics and Metabolism, 127(2), 132–137.
32.
PaolicelliR. C.BolascoG.PaganiF.MaggiL.ScianniM.PanzanelliP.GiustettoM.FerreiraT. A.GuiducciE.DumasL.RagozzinoD.GrossC. T. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science, 333(6048), 1456–1458.
33.
PärttyA.KalliomäkiM.WacklinP.SalminenS.IsolauriE. (2015). A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: A randomized trial. Pediatric Research, 77(6), 823–828.
34.
PetersonJ.WelchV.LososM.TugwellP. J. (2011). The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute.
PosnerJ.RauhV.GruberA.GatI.WangZ.PetersonB. S. (2013). Dissociable attentional and affective circuits in medication-naïve children with attention-deficit/hyperactivity disorder. Psychiatry Research Neuroimaging, 213(1), 24–30.
37.
Prehn-KristensenA.ZimmermannA.TittmannL.LiebW.SchreiberS.BavingL.FischerA. (2018). Reduced microbiome alpha diversity in young patients with ADHD. PLoS One, 13(7), e0200728.
38.
QuévrainE.MaubertM. A.MichonC.ChainF.MarquantR.TailhadesJ.MiquelS.CarlierL.Bermúdez-HumaránL. G.PigneurB.LequinO.KharratP.ThomasG.RainteauD.AubryC.BreynerN.AfonsoC.LavielleS.GrillJ. P.SeksikP. (2016). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut, 65(3), 415–425.
39.
RabinerD. L. (2013). Stimulant prescription cautions: Addressing misuse, diversion and malingering. Current Psychiatry Reports, 15(7), 375.
40.
RicharteV.Sánchez-MoraC.CorralesM.FadeuilheC.Vilar-RibóL.ArribasL.GarciaE.Rosales-OrtizS. K.Arias-VasquezA.Soler-ArtigasM.RibasésM.Ramos-QuirogaJ. A. (2021). Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder. Translational Psychiatry, 11(1), 382.
41.
ShawP.EckstrandK.SharpW.BlumenthalJ.LerchJ. P.GreensteinD.ClasenL.EvansA.GieddJ.RapoportJ. L. (2007). Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences, 104(49), 19649–19654.
42.
SherwinE.SandhuK. V.DinanT. G.CryanJ. F. (2016). Maythe force be with you: The light and dark sides of the microbiota-gut-brain axis in neuropsychiatry. CNS Drugs, 30(11), 1019–1041.
43.
Shirvani RadS.NikkhahA.OrvatiniaM.EjtahedH. S.SarhangiN.JamaldiniS. H.KhodayariN.Aghaei MeybodiH. R.HasanzadM. (2020). Gut microbiota: A perspective of precision medicine in endocrine disorders. Journal of Diabetes & Metabolic Disorders, 19, 1827–1834.
44.
ShirvaniradS.NikkhahA.OrvatiniaM. M.EjtahedH.-S.SarhangiN.MeybodiH. R. A.HasanzadM. (2021). The microbiome in precision medicine: A new approach to cancer treatment. Journal of Mazandaran University of Medical Sciences, 31(193), 21–37.
45.
SimonV.CzoborP.BálintS.MészárosA.BitterI. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. The British Journal of Psychiatry, 194(3), 204–211.
46.
StevensA. J.PurcellR. V.DarlingK. A.EgglestonM. J. F.KennedyM. A.RucklidgeJ. J. (2019). Human gut microbiome changes during a 10 week randomised control trial for micronutrient supplementation in children with attention deficit hyperactivity disorder. Scientific Reports, 9(1), 10128.
47.
SukmajayaA. C.LusidaM. I.SetiawatiY. (2021). Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD). Annals of General Psychiatry, 20(1), 12.
48.
Szopinska-TokovJ.DamS.NaaijenJ.KonstantiP.RommelseN.BelzerC.BuitelaarJ.FrankeB.AartsE.Arias VasquezA. (2020). Investigating the gut microbiota composition of individuals with attention-deficit/hyperactivity disorder and association with symptoms. Microorganisms, 8(3), 406.
49.
WangL.-J.YangC. Y.ChouW. J.LeeM. J.ChouM. C.KuoH. C.YehY. M.LeeS. Y.HuangL. H.LiS. C. (2020). Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry, 29(3), 287–297.
50.
WanL.GeW. R.ZhangS.SunY. L.WangB.YangG. (2020). Case-control study of the effects of gut microbiota composition on neurotransmitter metabolic pathways in children with attention deficit hyperactivity disorder. Frontiers in Neuroscience, 14, 127.
51.
WongM.-L.InserraA.LewisM. D.MastronardiC. A.LeongL.ChooJ.KentishS.XieP.MorrisonM.WesselinghS. L.RogersG. B.LicinioJ. (2016). Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Molecular Psychiatry, 21(6), 797–805.
52.
WuH.JerseA. E. (2006). α-2,3-Sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infection and Immunity, 74(7), 4094–4103.
